Latest Market Research Updates

Flexible & Semi-rigid Ureteroscopy Market Is Projected To Reach $1.12 Billion By 2025

The global flexible & semi-rigid ureteroscopy market size is expected to reach USD 1.12 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.1% over the forecast period. Increasing incidence of urolithiasis coupled with growing geriatric and obese population is likely to drive the market. Furthermore, introduction of technologically advanced products is also projected to drive the growth.

According to the U.S. Department of Commerce, in 2015, the world population was 7.3 billion, out of which around 8.5% or 617.1 million people were aged 65 years and more. The rapid increase in elderly population is likely to drive growth of the market for flexible and semi-rigid ureteroscopy over the forecast period.

Ureteroscopy is an ideal and safe choice for treating ureteral stones, tumors or strictures. Introduction of technologically advanced products in terms of size and design has allowed ureteroscopes to easily access ureter and kidney, eliminating the need for any surgical incision. Also, with semi-rigid and flexible ureteroscopes; almost all parts of urinary tract can be easily assessed, with high quality digital optics enabling accurate assessment of mucosal lesions and stones.

Introduction of technologically advanced products such as single-use ureteroscopes is driving the market. For instance, Boston Scientific launched LithoVue, a new single-use digital ureteroscope, in U.S. and Europe. It provides high-quality digital visualization and seamless navigation for constant clinical performance during each procedure. Flexible ureteroscopes was the largest product segment in 2017 and is likely to witness fastest growth over the forecast period. The wide usage of these products is attributed to their accuracy and cost effectiveness.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/flexible-semi-rigid-ureteroscopy-market

Further key findings from the report suggest:

The urolithiasis segment is expected to hold largest market share, mainly due to the high prevalence of kidney stone
Hospitals was the largest segment of the flexible and semi-rigid ureteroscopy in 2017 as majority of diagnostic tests are performed in hospitals, mainly due to easy access
Ambulatory surgical centers segment is expected to witness significant growth over the forecast period. As the payers and government analyze costs and shift towards value-based care, outpatient surgery is likely to witness a rise
North America was the largest revenue generating region in 2017, followed by Europe. North America is the most well-established region in terms of usage of ureteroscopes and makes up most of the existing market
Asia Pacific is likely to witness the fastest growth over the forecast period due to unmet clinical needs and requirement for better diagnosis. Growing government initiatives and clinical research activities for advanced diagnostics are expected to further propel the regional growth
The players operating in this space are Boston Scientific, Olympus, Karl Storz Medical AG, Stryker, Elmed Medical Systems, Maxer Endoscopy, Richard Wolf, and Vimex Endoscopy. Most companies adopt strategies such as geographic expansion, business collaborations, and introducing technologically advanced products to increase their market share.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Trauma Devices Market Is Projected To Reach $11.2 Billion By 2025

The global trauma devices market size is expected to reach USD 11.2 billion in 2025, according to a new report by Grand View Research, Inc., registering a 6.1% CAGR during the forecast period. Increasing incidence of severe fractures and rising expenditure on research and development of trauma devices are among key factors likely to drive the market during the forecast period. Medical devices used for fixation of small bones and joints are categorized under orthopedic trauma.

The market for trauma devices is likely to witness high growth in the coming years due to rising geriatric population and surge in number of road accidents. The market is driven by technological advancements, with key players introducing array of products through extensive research capabilities and expanding their segment portfolio through partnerships with other players.

For instance, in July 2017, Cardinal Health acquired the patient recovery business from Medtronic for USD 6.1 billion. The acquisition helped expand Cardinal Health’s portfolio by adding 23 product categories, including segment leader brands such as Kendall, Curity, Kangaroo, Dover, and Argyle.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/trauma-devices-market

Further key findings from the report suggest:

Rising number of road accidents and increase in expenditure on research and development is expected to drive the trauma devices market from 2018 to 2025
Osteoporotic fractures affect around 8.9 million people every year, mainly menopausal women, and causes osteoporotic fracture in more than 30.0% women over the age of 50
Around 40.0% of trauma injuries occur due to falls and motor vehicle accidents. Elderly population as well as children below the age of 7 are more prone to falls. Motor vehicle accidents account for over 28% of trauma injuries
Internal fixators dominated the market by type in 2017; however, external fixators are anticipated to grow at the fastest rate over the forecast period
Key industry contributors include Depuy Synthes, Stryker; Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Integra LifeSciences, Acumed, Bioretec Ltd., and Cardinal Health.

About Grand View Research

Retinal Surgery Devices Market Is Poised To Reach $3.06 Billion By 2025

The global retinal surgery devices market is expected to reach USD 3.06 billion by 2025, according to a new report by Grand View Research, Inc. The unprecedented growth is presumed to be a consequence of growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include less incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological upgradations that are responsible for heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in future. The technologically advanced devices are equipped with fundus imaging units, micro incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedure. For instance, launch of VersaVIT 2.0 vitrectomy machine which is equipped with LED illumination system, 3 vitrectomy packs and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle that eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency and control.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/retinal-surgery-devices-market

Further key findings from the report suggest:

Retinal laser equipment are predicted to observe exponential growth owing to consistency in usage of wide range of retinal operative procedures, high cost-efficiency, availability, and easy operability of the products
Diabetic retinopathy emerged as the largest application segment in 2016 as a consequence of high prevalence, raising the clinical urgency to adopt retinal surgery devices, thereby, fueling their penetration scope over the coming years
Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent new product approvals
The market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
Some of the key players of the market include Baush & Lomb Incorporated, IRIDEX Corporation Synergetics, Inc., accounting for the dominant share of retinal surgery devices market in 2016
The competition is marked by companies indulging in number of mergers & acquisitions, distribution agreements, and product approvals leading to significant growth
For instance, in February 2017, IRIDEX Corporation received FDA approval for its CYCLO G6 which has combined trans-illumination and laser fiber thereby expanding their product portfolio

About Grand View Research

Medical Tourism Market Is Projected To Reach $179.6 Billion By 2026

The global medical tourism market size is expected to reach USD 179.6 billion by 2026, according to a new report by Grand View Research, Inc., registering a 21.9% CAGR during the forecast period. Medical tourism generates direct foreign exchange income and contributes to the overall development of any economy. It also provides employment and business opportunities for residents. Moreover, it aids the growth of associated businesses such as pharmaceuticals, medical devices, and tourism. Government support to maintain the general reputation and political stability of the host country is a key factor driving the medical tourism market.

Government authorities are willing to invest in local enterprises to capitalize on the growth of medical tourism. Such government bodies have been authorizing projects that help in the overall development of infrastructure in a country, such as public transport system and water supply facilities, to attract high-end medical travelers.

Medical tourism has led to a rise in state-of-the-art medical facilities in developing countries to attract foreign nationals, resulting in fast growth of healthcare infrastructure in such countries. Moreover, healthcare providers now offer comprehensive medical tourism packages that include services ranging from ticket booking to hotel stay and medical insurance.

Thailand dominated the market in terms of revenue in 2018 owing to low cost and good quality medical services offered in the country. In 2016, Thailand ranked 18th in the International Healthcare Research Center’s Medical Tourism Index. Moreover, the country ranked 13th on the same index in terms of quality of facilities and services provided owing to well-developed healthcare infrastructure and increasing number of medical professionals. Thailand is also home to Asia’s first largest private hospital, Bumrungrad International Hospital, which is also the first hospital to receive a JCI accreditation and ISO 9001 certification. Till date, over 53 private hospitals have received JCI accreditation.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-tourism-market

Further key findings from the report suggest:

While Thailand is popular for cosmetic procedures, India is most preferred for cardiovascular and orthopedic procedures. Brazil and Costa Rica, on the other hand, are preferred for dental procedures
Thailand dominated the market in terms of revenue in 2018 due to the massive difference in treatment cost compared to developed countries. Around 2.4 million people visited Thailand to seek medical care in 2017 owing to low cost and good quality medical services
Singapore, Colombia, Taiwan, and Spain are some of the fastest growing medical tourism destinations in this market. Medical tourism is an important source of revenue generation for these countries, boasting advanced healthcare infrastructure and skilled manpower to cater to international patients
Bumrungrad International Hospital and Apollo Hospitals Enterprise Ltd. are the leading treatment destinations for medical tourism in Thailand and India respectively. Other prominent examples include Mexicali Bariatric Center in Mexico and TMC Fertility in Malaysia.

About Grand View Research

Insulin Delivery Devices Market Is Projected To Reach $19.8 Billion By 2025

The insulin delivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.

Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market

Further Key Findings from the Study Suggest:

The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector’s highest share in this market.
Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.
North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth.
The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.
Some key players serving this vertical include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton, Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd.

About Grand View Research

Angiography Equipment Market Is Predicted To Reach $16.2 Bn By 2026

The global angiography equipment market size is expected to reach USD 16.2 billion by 2026, according to a new report by Grand View Research, Inc. The market is expected to witness an exponential CAGR of 6.5% over the forecast period due to growing geriatric population, increasing prevalence of Cardiovascular Diseases (CVDs) with associated risk factors, technological advancements, and investments in the health tech sector. According to the World Health Organization (WHO) report, CVD is one of the leading causes of death in countries, such as U.S. and U.K.

Coronary Artery Disease (CAD) is the most prevalent form of CVD. Through Global Hearts Initiative, the WHO is supporting governments in controlling cardiovascular risk factors, such as hypertension and diabetes. All these factors are projected to boost the market expansion over the forecast period. Rapid development of the diagnostic imaging modalities providing better visualization and assessment of CVD is also likely to drive the angiography devices market in the years to come.

Geographically, North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. Countries, such as Brazil and China, export the medical devices from U.S. owing to the high standard of quality. Due to favorable government regulations in developing countries, such as Japan and China, the Asia Pacific region is projected to expand at a healthy CAGR during the estimated period. For instance, reimbursement policy in Japan encourages the local manufacturers to provide advanced angiography diagnostic devices.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/angiography-device-market

Further key findings from the study suggest:

Angiography systems led the market in 2018 owing to the advancements in technology and interventional procedures in Cath labs
In 2018, X-ray held the largest share of the market due to technological developments offering superior-quality and high-resolution images without increasing radiation dose
Coronary angiography led the procedure segment due to increased prevalence of Cardiovascular Diseases (CVDs)
In 2018, diagnostic angiography accounted for the largest share of the application segment due to the growing complexity of the diseases
Some key companies in the industry are GE Healthcare; Koninklijke Philips N.V.; Siemens Healthineers; Boston Scientific Corporation; Abbott Laboratories; B. Braun Melsungen; Medtronic, Inc.; Angiodynamics; Cordis Corporation; and Shimadzu Corporation

About Grand View Research

Nephrology & Urology Devices Market Is Poised To Reach $31.3 Billion By 2024

The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.

This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.

Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.

Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.

To request a sample copy or view summary of this report, click the link below:

https://www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market

Further key findings from the report suggest:

The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024
By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period
Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions
Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years
The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period
Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.

About Grand View Research

Latest Market Research Updates

Flexible & Semi-rigid Ureteroscopy Market Is Projected To Reach $1.12 Billion By 2025

Trauma Devices Market Is Projected To Reach $11.2 Billion By 2025

Retinal Surgery Devices Market Is Poised To Reach $3.06 Billion By 2025

Medical Tourism Market Is Projected To Reach $179.6 Billion By 2026

Insulin Delivery Devices Market Is Projected To Reach $19.8 Billion By 2025

Angiography Equipment Market Is Predicted To Reach $16.2 Bn By 2026

Nephrology & Urology Devices Market Is Poised To Reach $31.3 Billion By 2024

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Report Abuse

Labels